CD4 and vitiligo: Although the immunopathologic mechanism is not precisely known, lesional CD4+ T cells with a Th17 phenotype, melanocyte-specific CD8+ T cells, and defects in regulatory T (Treg) cells are found in vitiligo patients (19–23).